Michael F. MacLean
2020
In 2020, Michael F. MacLean earned a total compensation of $2.2M as Chief Financial Officer at Avidity Biosciences.
Compensation breakdown
| Non-Equity Incentive Plan | $129,200 |
|---|---|
| Option Awards | $1,857,763 |
| Salary | $247,765 |
| Other | $488 |
| Total | $2,235,216 |
MacLean received $1.9M in option awards, accounting for 83% of the total pay in 2020.
MacLean also received $129.2K in non-equity incentive plan, $247.8K in salary and $488 in other compensation.
Rankings
In 2020, Michael F. MacLean's compensation ranked 5,023rd out of 13,090 executives tracked by ExecPay. In other words, MacLean earned more than 61.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,023 out of 13,090 | 62nd |
Division Manufacturing | 2,050 out of 5,621 | 64th |
Major group Chemicals And Allied Products | 817 out of 2,254 | 64th |
Industry group Drugs | 706 out of 1,954 | 64th |
Industry Pharmaceutical Preparations | 531 out of 1,459 | 64th |
Source: SEC filing on April 29, 2021.
MacLean's colleagues
We found two more compensation records of executives who worked with Michael F. MacLean at Avidity Biosciences in 2020.